Insider-Backed Rights Issue Strengthens Lifecare’s Capital-Raising Effort

Lifecare AS ( (DE:LFC0) ) has issued an announcement.

Lifecare ASA has detailed participation in its ongoing partially underwritten rights issue, in which existing shareholders received subscription rights entitling them to subscribe for new shares at NOK 0.50 per share, with each subscription right granting the holder one new share. Subscribers will also receive, at no cost, two series of warrants—three warrants of Series 1 and three warrants of Series 2 for every four new shares subscribed and paid—providing future exercise opportunities in March and June 2026, respectively; Hannibal Invest AS, a company closely associated with board member Hans Hekland, has subscribed for 200,000 new shares (mostly via subscription rights, plus an over-subscription portion) and a total of 300,000 warrants, underscoring insider support for the capital raise and signaling confidence in Lifecare’s financing structure and growth prospects.

More about Lifecare AS

Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on bringing next-generation continuous glucose monitoring systems to market. Using osmotic pressure as its core sensing principle, the company targets both human and veterinary applications, aiming to detect and monitor a wide range of analytes and molecules in the body.

Average Trading Volume: 534,413

Current Market Cap: NOK164.3M

Learn more about LFC0 stock on TipRanks’ Stock Analysis page.